Literature DB >> 16767372

Antibody array-generated cytokine profiles of tears of patients with vernal keratoconjunctivitis or giant papillary conjunctivitis.

Jun Shoji1, Noriko Inada, Mitsuru Sawa.   

Abstract

PURPOSE: To investigate differences in the cytokine and chemokine profiles of patients with vernal keratoconjunctivitis (VKC) or giant papillary conjunctivitis (GPC).
METHODS: The study included six patients (six eyes) with VKC, five patients (five eyes) with GPC, and five healthy volunteers (five eyes) as controls. None of the patients had received any anti-allergic treatment prior to this study. One patient with VKC was given a tear examination to evaluate the effect of anti-inflammatory treatment with a steroid on the tear cytokine profile about the treatment. Tear samples were collected with the Schirmer I method, using filter paper. Tear samples were eluted and analyzed by an antibody array system for inflammation-related factors, including cytokines and chemokines.
RESULTS: In the patients with VKC, four inflammation-related factors, eotaxin, interleukin (IL)-11, monocyte chemoattractant protein (MCP)-1, and macrophage-colony stimulating factor (M-CSF) increased to four times the values in the control group, and seven inflammation-related factors, eotaxin-2, IL-4, IL-6, interleukin-6 soluble receptor (IL-6sR), IL-7, macrophage inflammatory protein (MIP)-1delta, and tissue inhibitor of metalloproteinases (TIMP)-2, increased to eight times the control values. In the patients with GPC, three inflammation-related factors, IL-6, M-CSF, and monokine-induced gamma interferon (MIG), increased to four times those in the control group, and five inflammation-related factors, eotaxin-2, IL-6sR, IL-11, MIP-1delta, and TIMP-2, increased to eight times the control values. The increase in IL-6sR relative to the controls was statistically significant in both the VKC and GPC groups. The increase in eotaxin-2 was significant only in the VKC group, and that in TIMP-2 was significant only in the GPC group, compared with the controls.
CONCLUSIONS: The present study demonstrated the presence of crucial cytokines, soluble cytokine receptors, and chemokines in tears of patients with VKC and GPC. In particular, IL-6sR increased significantly in both the VKC and GPC groups, whereas eotaxin-2 increased significantly only in the VKC group. Thus, IL-6sR may play an important pathophysiological role in giant papillary proliferation in VKC and GPC, and eotaxin-2 may play an important role in eosinophilic inflammation in VKC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16767372     DOI: 10.1007/s10384-005-0319-4

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.211


  27 in total

1.  Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis.

Authors:  E Maggi; P Biswas; G Del Prete; P Parronchi; D Macchia; C Simonelli; L Emmi; M De Carli; A Tiri; M Ricci
Journal:  J Immunol       Date:  1991-02-15       Impact factor: 5.422

2.  Increase of the soluble IL-4 receptor (IL-4sR) and positive correlation between IL-4sR and IgE in nasal fluids from school children with allergic rhinitis.

Authors:  M Benson; I L Strannegård; G Wennergren; O Strannegård
Journal:  Allergy Asthma Proc       Date:  2000 Mar-Apr       Impact factor: 2.587

3.  Increased eotaxin in tears of patients wearing contact lenses.

Authors:  Marilita M Moschos; Simone Eperon; Yan Guex-Crosier
Journal:  Cornea       Date:  2004-11       Impact factor: 2.651

4.  Efficacy of tear eosinophil cationic protein level measurement using filter paper for diagnosing allergic conjunctival disorders.

Authors:  Jun Shoji; Minoru Kitazawa; Noriko Inada; Mitsuru Sawa; Tetsuya Ono; Masahide Kawamura; Hiroshi Kato
Journal:  Jpn J Ophthalmol       Date:  2003 Jan-Feb       Impact factor: 2.447

5.  Tear chymase in vernal keratoconjunctivitis.

Authors:  Nobuyuki Ebihara; Toshinari Funaki; Shinji Takai; Mizuo Miyazaki; Keiko Fujiki; Akira Murakami
Journal:  Curr Eye Res       Date:  2004-06       Impact factor: 2.424

6.  Interleukin-6 and its soluble receptor cause a marked induction of collagenase 3 expression in rat osteoblast cultures.

Authors:  N Franchimont; S Rydziel; A M Delany; E Canalis
Journal:  J Biol Chem       Date:  1997-05-02       Impact factor: 5.157

7.  Phenotypic characterization of T cells infiltrating the conjunctiva in chronic allergic eye disease.

Authors:  D P Metz; A S Bacon; S Holgate; S L Lightman
Journal:  J Allergy Clin Immunol       Date:  1996-09       Impact factor: 10.793

Review 8.  Conjunctivitis of allergic origin: clinical presentation and differential diagnosis.

Authors:  M H Friedlaender
Journal:  Surv Ophthalmol       Date:  1993 Jul-Aug       Impact factor: 6.048

9.  Conjunctival deposition of eosinophil granule major basic protein in vernal keratoconjunctivitis and contact lens-associated giant papillary conjunctivitis.

Authors:  S D Trocme; G M Kephart; M R Allansmith; W M Bourne; G J Gleich
Journal:  Am J Ophthalmol       Date:  1989-07-15       Impact factor: 5.258

10.  Supratarsal injection of corticosteroid in the treatment of refractory vernal keratoconjunctivitis.

Authors:  D S Holsclaw; J P Whitcher; I G Wong; T P Margolis
Journal:  Am J Ophthalmol       Date:  1996-03       Impact factor: 5.258

View more
  12 in total

1.  Antibody protein array analysis of the tear film cytokines.

Authors:  Shimin Li; Robert Sack; Trinka Vijmasi; Sonal Sathe; Ann Beaton; David Quigley; Marianne Gallup; Nancy A McNamara
Journal:  Optom Vis Sci       Date:  2008-08       Impact factor: 1.973

2.  Topical loteprednol etabonate 0.5 % for treatment of vernal keratoconjunctivitis: efficacy and safety.

Authors:  Veysi Oner; Fatih Mehmet Türkcü; Mehmet Taş; Mehmet Fuat Alakuş; Yalçın Işcan
Journal:  Jpn J Ophthalmol       Date:  2012-05-25       Impact factor: 2.447

3.  Membrane array analysis of tear proteins in ocular cicatricial pemphigoid.

Authors:  Matilda F Chan; Robert Sack; David A Quigley; Sonal Sathe; Trinka Vijmasi; Shimin Li; Douglas Holsclaw; Erich C Strauss; Nancy A McNamara
Journal:  Optom Vis Sci       Date:  2011-08       Impact factor: 1.973

4.  Concentration of soluble interleukin-6 receptors in tears of allergic conjunctival disease patients.

Authors:  Jun Shoji; Atsuri Kawaguchi; Aki Gotoh; Noriko Inada; Mitsuru Sawa
Journal:  Jpn J Ophthalmol       Date:  2007-10-05       Impact factor: 2.447

5.  Simultaneous study of matrix metalloproteinases, proinflammatory cytokines, and soluble cytokine receptors in the tears of noninfectious corneal ulcer patients.

Authors:  Tohru Sakimoto; Takako Ohnishi; Akiko Ishimori
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-09       Impact factor: 3.117

6.  Evaluation of eotaxin-1, -2, and -3 protein production and messenger RNA expression in patients with vernal keratoconjunctivitis.

Authors:  Jun Shoji; Noriko Inada; Mitsuru Sawa
Journal:  Jpn J Ophthalmol       Date:  2009-03-31       Impact factor: 2.447

7.  Investigation of the human tear film proteome using multiple proteomic approaches.

Authors:  Kari B Green-Church; Kelly K Nichols; Nan M Kleinholz; Liwen Zhang; Jason J Nichols
Journal:  Mol Vis       Date:  2008-03-07       Impact factor: 2.367

Review 8.  Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine.

Authors:  Suzanne Hagan; Eilidh Martin; Amalia Enríquez-de-Salamanca
Journal:  EPMA J       Date:  2016-07-13       Impact factor: 6.543

9.  Quiescent and Active Tear Protein Profiles to Predict Vernal Keratoconjunctivitis Reactivation.

Authors:  Alessandra Micera; Antonio Di Zazzo; Graziana Esposito; Roberto Sgrulletta; Virginia L Calder; Stefano Bonini
Journal:  Biomed Res Int       Date:  2016-02-17       Impact factor: 3.411

Review 10.  Potential Biomarkers for Allergic Conjunctival Diseases.

Authors:  Neeta Roy; Shir Levanon; Penny A Asbell
Journal:  Eye Contact Lens       Date:  2020-03       Impact factor: 3.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.